Darwin's Medicine: How Business Models in the Life Sciences Industry are Evolving

— —

Brian D. Smith

Darwin's Medicine

How Business Models in the Life Sciences Industry are Evolving

Brian D. Smith

$284

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Routledge
19 October 2016

Economics; Business strategy; International business; Research & development management; Pharmaceutical industries

Darwin’s Medicine is the sequel to Brian D. Smith’s influential and critically acclaimed Future of Pharma (Gower, 2011). Whereas the earlier book predicted the evolution of the pharmaceutical market and the business models of pharmaceutical companies, Darwin’s Medicine goes much deeper into the drivers of industry change and how leading pharmaceutical and medical technology companies are adapting their strategies, structures and capabilities in practice.

Through the lens of evolutionary science, Professor Smith explores the speciation of new business models in the Life Sciences Industry. This sophisticated and highly original approach offers insights into:

The mechanisms of evolution in this exceptional industry; The six great technological and social shifts that are shaping its landscape; The emergence of 26 distinct, new business models; and The lessons that enable firms to direct and accelerate their own evolution.

These insights map out the industry’s complex, changing landscape and provide an invaluable guide to those firms seeking to survive and thrive in this dynamic market.

The book is essential reading for anyone working in or studying the pharmaceutical, medical technology and related sectors. It provides a unique and novel way of making sense of the transformation we can see going on around us and a practical, focused approach to managing a firm’s evolutionary trajectory.

By: Brian D. Smith
Imprint: Routledge
Country of Publication: United Kingdom
Dimensions: Height: 246mm, Width: 174mm, Spine: 20mm
Weight: 690g
ISBN: 9781472420718
ISBN 10: 1472420713
Pages: 296
Publication Date: 19 October 2016
Audience: Professional and scholarly , College/higher education , Undergraduate , Primary
Format: Hardback
Publisher's Status: Active

Part 1: The Future of Pharma - Reprise 1. Introduction and an Invitation to Skip a Chapter 2. An Important Industry at Risk 3. The Best Idea Anyone Has Ever Had 4. The Biologists Got There First 5. Applying Evolutionary Theory to the Pharmaceutical and Medical Technology Sectors 6. Explaining the Industry’s Past 7. Predicting the Future of Pharma and Medtech 8. Practical Implications for an Evolving Industry 9. Watching the Future Unfold Part 2: An Immeasurably Superior Power 10. Introduction: The Emergent Pressures of Selection 11. Selection Pressures Emerging from the Social Environment 12. Selection Pressures Emerging from the Technological Environment 13. Asking the Right Questions Part 3: Evolution is Cleverer Than You Are 14. Introduction: Orgel’s Second Law 15. Technological Innovator Species Emerging in the Government Payer Habitat 16. Technological Innovator Species Emerging in Patient Payer Habitats 17. Operationally Excellent Species Emerging in the Government Payer Habitat 18. Operationally Excellent Species Emerging in Patient Payer Habitats 19. Customer Intimate Species Emerging in the Government Payer Habitat 20. Customer Intimate Species Emerging in Patient Payer Habitats 21. A Big Bang of Life Science Business Models Part 4: Guiding the Blind Watchmaker 22. Introduction: From Description to Prescription 23. Which Fitness Peak(s) Should We Climb? 24. What Capabilities Does Our New Business Model Need? 25. How Should We Design a Capable Holobiont? 26. How Do We Build Our Core Capabilities?

Professor Brian D. Smith began his career as a research chemist in a pharmaceutical R&D lab and then spent 20 years in technical and marketing roles before becoming an academic, author and adviser. Working at The University of Hertfordshire and SDA Bocconi, two of Europe's leading business schools, his research focuses on strategy creation and implementation in pharmaceutical and medical technology markets. Brian also runs a specialist consultancy that advises many of the world's largest companies in this sector. He is editor of the Journal of Medical Marketing, has written and co-written three major books, including The Future of Pharma (Gower, 2011), and published many practitioner articles - all of which can be seen at www.pragmedic.com.